Auto saved by Logseq

master
borja 2 months ago
parent 15f5cc35e8
commit d8db319a43

@ -20,7 +20,8 @@
- Demonstrating that doing the pivotal trial and submit to regulatory agencies doesn't mean inclusion in programs. - Demonstrating that doing the pivotal trial and submit to regulatory agencies doesn't mean inclusion in programs.
- I got in touch with EDCTP authorities to highlight that PZQ and moxi and fdc are all edctp invesments. They are very happy about it. - I got in touch with EDCTP authorities to highlight that PZQ and moxi and fdc are all edctp invesments. They are very happy about it.
- Maurice: what i gather is present the clinical findings and highlight what the next steps are. Im not in the access program. I just know generalically. They're trying to get aproval in Kenya. I cannot give many specifics but yes about the pivotal trials. The panel can take it from there. - Maurice: what i gather is present the clinical findings and highlight what the next steps are. Im not in the access program. I just know generalically. They're trying to get aproval in Kenya. I cannot give many specifics but yes about the pivotal trials. The panel can take it from there.
- Stella: Those iinvolved in the access will be in the audience. Look at the path from inception to - Stella: Those iinvolved in the access will be in the audience. Look at the path from inception to regulatory and next steps.
- Has the pzq been adopted in WHO recomendations. It was adopted in March of 2024. That is a big step. You're leading this. FDC is not there yet. Highlighjting that all the activities to include it in recomendaitons has already been acomp
- ### Decisiones - ### Decisiones
- -
- CANCELED 17:00 - 17:30: Pre-Symposium meeting - CANCELED 17:00 - 17:30: Pre-Symposium meeting

Loading…
Cancel
Save